Compare Google Inc (GOOG) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Google Inc vs Repligen Corporation Common Stock — how do they compare? Google Inc trades at $339.06 (market cap $4.30T), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Google Inc is far larger — about 386× Repligen Corporation Common Stock's market cap, and Google Inc pays a 0.25% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Google Inc for 138 Days and Repligen Corporation Common Stock for 0 Days on average.
| GOOG | RGEN | |
|---|---|---|
Market Cap | $4.30T | $11.14B |
Volume | 14,394,061 | 1,259,263 |
Sector | Media | Health |
52-Week High | $399.06 | $194.57 |
52-Week Low | $251.34 | $102.87 |
Typical Hold Time | 138 Days | 0 Days |
Enterprise Value | $4.19T | $11.02B |
Dividend Yield | 0.25% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOG) trades at $349.52, up 0.16% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust revenue growth to $402.84 billion in 2025, with net income surging to $132.17 billion and a net margin of 32.8%. Recent earnings beats and a consensus analyst price target of $435.29 highlight investor confidence, though high capital expenditures and legal challenges present near-term risks.
The outlook for GOOG remains positive driven by AI and cloud expansion, with projected 2026 revenue of $445.9 billion. However, rising capex leading to negative free cash flow projections and ongoing securities lawsuits pose significant risks. The stock's current valuation metrics, including a P/E of 17.54, suggest room for growth if execution continues, but investors should weigh these factors against the competitive and regulatory landscape.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Google Inc
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
